A New Agent “OSU-HDAC42″ Blocks Prostate Cancer In Mice
By on May 25th, 2008 |262 views
A new discovery by the researchers at Ohio State University Comprehensive Cancer Center , has led researchers to develop a drug “Agent” which was able to block prostate cancer in mice. The new agent refered to as “OSU-HDAC42″, which belongs to a new class of drugs called histone deacetylase inhibitors, compounds designed to reactivate genes that normally protect against cancer but are turned off by the disease process.
“This study shows that an agent with a specific molecular target can dramatically inhibit prostate cancer development in an aggressive model of the disease,” study co-author Dr. Steven Clinton of the Ohio State’s James Cancer Hospital and Solove Research Institute said. “We hope to see this agent in clinical trials soon and ultimately used for prostate-cancer prevention or therapy.”
If you enjoyed this post, make sure you subscribe by RSS feed Or By E-mail!People who read this also read
- Reduce Your Risk Of Developing Prostate Cancer Through Masturbation
- A New Way Of Cancer Treatment
- Broccoli May Reduce The Risk Of Developing Prostate Cancer
- Four commonly used moisturizers cause skin cancer in mice
- Smoking Causes Lung Cancer By Limiting The Production Of FANCD2 Protein
- Red Meat Could Promote Cancer Progression - Study Suggests
- A new cancer growth enzyme was discovered
- An Hour Or Two Walking Each Week Lowers Colon Cancer Risk In Women
Have an opinion? Leave a comment. No Registration Required.